RZLT · Rezolute, Inc.
Market Cap
$441.02M
Shares
96.29M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Nevan Charles Elam | Chief Executive Officer | $1,192,700 |
| Brian Roberts | Chief Medical Officer | $817,959 |
| Daron Evans | Chief Financial Officer | $384,065 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Nevan Charles Elam | Chief Executive Officer | $973,646 |
| Brian Roberts | Chief Medical Officer | $738,858 |
| Daron Evans | Chief Financial Officer | — |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Nevan Charles Elam | Chief Executive Officer | $7,781,300 |
| Brian Roberts | Chief Medical Officer | $2,423,148 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Nevan Elam | Chief Executive Officer | $4,896,732 |
| Nevan Charles Elam | Chief Executive Officer | $4,896,732 |
| Brian Roberts | Chief Medical Officer | $1,353,941 |
| Keith Vendola | Former Chief Financial Officer | $618,058 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Nevan Elam | Chief Executive Officer | $3,298,703 |
| Nevan Charles Elam | Chief Executive Officer | $3,298,703 |
| Sankaram Mantripragada | — | $1,066,633 |
| Keith Vendola | Former Chief Financial Officer | $952,716 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Keith Vendola | Former Chief Financial Officer | $735,372 |
| Nevan Charles Elam | Chief Executive Officer | $732,246 |
| Scientist Emeritus | — | $562,394 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Sunil Karnawat | Chief Commercial Officer | Appointed | 2025-08-20 |
Key facts
CIK
1509261
CUSIP
76200L309
13F (30d)
109 filings
109 filers
Visit website
Investor relations